Iron and aging

Iron is essential, but the body has no way to get rid of it, so in adults who aren't losing blood it slowly builds up, and genetic studies link higher iron to a somewhat shorter life. The case for actively lowering it is far weaker: bleeding people to cut iron hasn't been shown to prevent heart attacks, and drugs that pulled iron out of the brain made patients worse.

Don't take iron unless a blood test shows you are deficient, and have ferritin and transferrin saturation checked once a year, aiming for the low end of normal. Too little iron is as much a problem as too much, especially after 65, where low iron is a reason to see a doctor rather than to self-treat.

Why iron builds up

Iron is indispensable: it carries oxygen in haemoglobin, runs the chain of reactions that produces cellular energy, and sits in dozens of enzymes. The same chemistry makes loose iron dangerous, because it catalyses the most destructive free radical in biology. Humans evolved under iron scarcity and frequent blood loss, so the body has elaborate machinery to absorb and hoard iron but no regulated way to get rid of it. Once childhood growth and (in women) menstruation end, iron tends to creep upward for the rest of life: steadily in men, and in women after menopause, though women often never reach male levels.[1]

The genetic case: more iron, a somewhat shorter life

The strongest human evidence comes from genetics. People inherit gene variants that set their iron level slightly higher or lower for life, and because those variants are assigned at conception, comparing people by them (Mendelian randomisation) sidesteps most of the confounding that plagues diet studies. Each standard-deviation increase in genetically predicted blood iron went with roughly 0.7 fewer years of life (measured as parents' lifespan) and lower odds of reaching the oldest age bands.[2] A second, independent genetic study in Norway found the same pattern, with weak signs that more iron helps people whose levels sit below the normal range.[3] A large 2020 genetic study of healthspan and longevity pointed the same way.[4]

Disease by disease, the picture is not a single arrow. Genetic studies suggest higher iron lowers the risk of coronary artery disease[5] and, surprisingly, of Parkinson's disease, by about 3% per 10 µg/dL of blood iron, a direction the authors themselves call not yet clinically actionable.[6] It raises the odds of type 2 diabetes, by roughly 6–19% depending on the iron marker,[7] and of stroke caused by clots that form in the heart.[8] The net effect on lifespan is still negative, which is why "iron is bad" is too blunt.

People genetically inclined to higher iron also have "older" epigenetic clocks (blood-based estimates of biological age), by roughly 0.3 to 0.5 years per standard deviation, though those studies reuse the same genetic markers.[9] The genetic case is probably real but modest. It is causal-inference evidence rather than a trial, and it describes small lifelong differences, not what a supplement or a blood donation would do. Iron is not one of the 12 recognised hallmarks of aging,[10] but it feeds several of them: DNA damage, mitochondrial decline and cellular senescence.

How excess iron does damage

Inside a healthy cell, almost all iron is locked inside ferritin, a hollow protein shell that holds it in a chemically inert form. Aging erodes that control. Loose iron turns the small amounts of hydrogen peroxide that normal respiration makes into the hydroxyl radical, the most reactive oxidant the body generates, with no enzyme to neutralise it. It damages fats, proteins and DNA, and mitochondria, which use the most iron, take the worst of it.[11]

Iron also acts as a growth signal that helps keep the growth-sensing pathway mTOR (mechanistic target of rapamycin) switched on, which suppresses autophagy, the cell's recycling of damaged parts (see deregulated nutrient sensing). In worms, an iron-poor diet switches on stress-resistance programmes and extends lifespan.[12]

Newer ideas, such as worn-out "senescent" cells hoarding iron so they resist iron-driven cell death and linger, are cell and animal work only,[13] and no therapy aimed at iron-driven cell death (ferroptosis) is approved for any aging condition.

Haemochromatosis: proof that iron excess harms

The clearest human evidence that chronic iron excess does lasting damage comes from hereditary haemochromatosis, in which two faulty copies of the HFE gene let iron load without limit. About 1 in 150 people of European ancestry carry two copies.[14] In UK Biobank, men with the genotype were estimated by age 80 to have died more often (about 33% against 25%) and to have had more liver disease, joint replacements, dementia, delirium and Parkinson's disease, even if never diagnosed.[15] Their liver-cancer risk was roughly ten times higher.[16] Women with the genotype had more liver disease, joint replacements and delirium, though less than men,[17] and no clear excess in deaths.[18] The damage is largely preventable by regular blood removal, which makes this a hard-outcome anchor for the whole case.

Lowering iron: the treatment case is weak

In 1981 Jerome Sullivan proposed that premenopausal women have less heart disease than men because menstrual blood loss keeps their iron stores low, and that the protection fades as iron builds up after menopause.[19] The mechanism is coherent: stored iron helps oxidise LDL cholesterol, and oxidised LDL is what builds arterial plaque.

The one large randomised test failed. Repeatedly removing blood to lower iron in about 1,300 people with peripheral artery disease did not reduce deaths, or deaths plus heart attacks and strokes.[20] The youngest quarter, roughly ages 43 to 61, did better, but a subgroup inside an overall-negative trial only generates a hypothesis. A 2026 pooled analysis of small studies and a small trial, both from one research group, found that removing blood slightly improves insulin resistance on lab tests in people with metabolic problems linked to high ferritin and in overweight donors with prediabetes,[21][22] but nobody has shown that this prevents diabetes, heart attacks or deaths. Avoiding iron overload is sound; bleeding healthy people for their hearts is not established.

Blood donation reliably lowers iron stores and helps someone else. The lower death rates in donor studies are heavily confounded by the "healthy donor effect" (donors have to be well to give), so donate for others, not as a longevity treatment. Donating too often drains iron, bringing lower haemoglobin and ferritin and more tiredness and dizziness,[23] and the routine haemoglobin check at donation doesn't catch it, so regular donors should get ferritin checked; Dutch centres now defer donors for 6 months when ferritin is below 30 µg/L, and 12 months below 15 µg/L.[24]

Brain iron: part of the disease, but lowering it backfired

In aging mice, the brain makes more of the hormone hepcidin, which destroys the cell's only iron exporter and traps iron inside.[25] Iron concentrates in the brain region damaged in Parkinson's and speeds the build-up of the amyloid and tau proteins of Alzheimer's.[26] Genetic evidence now points to a causal role: in about 40,000 UK Biobank adults, genetically higher iron in specific deep brain regions raised the risk of Parkinson's and some non-Alzheimer dementias, though not Alzheimer's itself.[27] Brain iron and body iron are different things, and lowering body iron does not seem to clear brain iron.[28]

The trials that lowered brain iron made things worse. Deferiprone, a drug that crosses into the brain and pulls iron out, worsened movement scores against placebo over 36 weeks in newly diagnosed, untreated Parkinson's, probably because iron is needed to make dopamine.[29] In early Alzheimer's it sped cognitive decline over a year, with more frontal brain shrinkage.[30] In a rare inherited brain-iron-overload disease it showed only a trend toward slower progression that missed statistical significance.[31] So iron is one thread in dementia risk, not a lever; the established ones are under dementia prevention.

Food and supplements: the source matters more than the total

Heme iron, from red meat, poultry and fish, is absorbed at 15–35% through a route the body only partly throttles when stores are full, and it is a pro-oxidant in the gut. In three large US cohorts followed for decades, people eating the most heme iron had about a quarter higher risk of type 2 diabetes than those eating the least, and heme iron accounted for roughly two-thirds of the diabetes risk linked to unprocessed red meat.[32] See red and processed meat.

Non-heme iron, from plants and fortified foods, is absorbed at 2–20%, and the gut takes up less when stores are adequate. In the same US cohorts it was unrelated to diabetes,[33] and in a Chinese cohort of about 6,000 adults the highest intake went with about 30% lower risk of developing two or more cardiometabolic diseases over six years.[34]

Non-heme absorption is easy to steer at the table. Polyphenols and tannins (in tea, coffee and cocoa) and phytates (in legumes and whole grains) can cut it by half or more: in single-meal studies, a cup of tea cut absorption by about two-thirds and a cup of coffee by about 40%.[35] Timing matters too, and coffee covers it. See also tea. Vitamin C does the opposite, sharply increasing absorption.

Supplements are where the caution lies. They deliver a large, unregulated dose, and no benefit has been shown in people who are not deficient. In US national survey data, adults whose total intake ran above the 45 mg/day upper limit, mostly from supplements, had blood-biomarker ages about 1.8 years older, partly through inflammation,[36] while iron from food went with a younger biological age.[37] These are snapshot surveys that cannot prove cause.

What to measure

Standard lab ranges are built to catch overt anaemia or full iron overload, not to judge where you sit within the healthy range. Two cheap tests carry most of the signal, and both are U-shaped: too little is as bad as too much.

MarkerTypical lab rangeAim forWhy
Ferritin (stored iron)~10–300+ µg/LAbove 30 µg/L; below 150 µg/L (women who menstruate) or 200 µg/L (men, other women)Under 30 usually means deficiency [38]; 200 or more went with about 10% higher mortality in a Danish cohort [39]
Transferrin saturation (iron in transit)20–50%24–40%Above about 55% went with roughly 60% higher mortality in US adults followed from the early 1970s [40]; a later US analysis saw risk rise above about 50%, while people above the lowest quarter (under about 17%) had 6–8% lower mortality than those in it [41]; below 20% signals iron restriction [42]

No narrower ferritin target has been tested in a trial. In a Danish study of about 162,000 adults whose doctors had ordered blood tests, the lowest mortality among those without marked inflammation sat near 60 µg/L in women and 125 µg/L in men, an association rather than a target.[43] Lower is not simply better either: comparing people who reached 100 with people over 92 who died before 100, those with middling ferritin were about 20% more likely to reach 100 than those with the lowest levels, while the highest levels showed no clear advantage; the study is observational.[44]

Ferritin is also an inflammation marker, so read a high value alongside high-sensitivity C-reactive protein and transferrin saturation before calling it overload. High ferritin with normal inflammation and saturation above about 45% warrants a haemochromatosis work-up. Don't act on a single value taken during illness or hard training. The full panel is in midlife labs.

The other side of the U: too little iron

Deficiency is the more common everyday problem, especially in premenopausal women, endurance athletes, frequent blood donors and long-term plant-based eaters. It causes fatigue, hair loss, poor exercise recovery, restless legs and impaired thinking, sometimes before ferritin drops below the usual cutoffs; for restless legs, the US sleep-medicine guideline advises iron at a ferritin of 75 µg/L or below, an expert-consensus figure.[45] Cutoffs differ: the World Health Organization uses ferritin below 15 µg/L in healthy adults (70 µg/L during inflammation) and UK guidance 30 µg/L;[46] some experts argue for 45–50 µg/L, which WHO has not adopted.[47] The goal is low-normal, not empty.

In older adults, deficiency becomes a serious clinical problem. Anaemia affects roughly one in ten community-dwelling people over 65 and more than one in five past 85.[48] Even mild anaemia tracks with higher mortality at these ages, and US death-certificate data for people over 65 show deaths with iron-deficiency anaemia listed as a cause holding steady from 1999 to 2013, then rising by about 10% a year to 2019.[49]

But iron deficiency explains only about one-sixth of anaemia in older people; inflammation, kidney disease and unexplained causes make up the rest. True depletion needs replacement. Anaemia of chronic inflammation, where the hormone hepcidin locks iron away, does not, and supplementing it does nothing useful and may cause harm. A low ferritin can also flag hidden bleeding or cancer, so low iron in an older adult is a reason for a clinical work-up, not for self-treatment. Even when deficiency is real, correcting it is not a longevity lever: in adults with heart failure and genuine iron deficiency, three large trials of intravenous iron found at most a small, borderline drop in heart-failure hospital stays and no clear gain in survival.[50][51][52] Fixing a real deficiency is still worth doing.

What to actually do

  1. Don't take iron unless a blood test shows deficiency. Multivitamins with iron are unnecessary for most adults who don't menstruate.
  2. Check ferritin and transferrin saturation yearly and aim for the ranges in the table.
  3. Keep unprocessed red meat occasional rather than daily. Its protein and vitamin B12 are available from fish, poultry and plants with less heme iron.
  4. Use tea or coffee with iron-rich meals if your iron is high-normal, and vitamin C with plant iron if it is low.
  5. Donate blood if you can, within limits: roughly 3–4 times a year for men and 1–2 for premenopausal women, at least 12 weeks apart for men and 16 for women, with a ferritin check if you donate regularly.[53]
  6. Get clinical advice rather than following general rules if you have haemochromatosis, anaemia or kidney disease.

What's overrated

  • Iron-chelating supplements for "brain detox." Green-tea EGCG (epigallocatechin gallate) does bind iron and reaches the brain in lab models,[54] but human evidence for slowing neurodegeneration this way is preliminary, and high-dose green tea extract carries a liver-toxicity risk. Drinking tea is fine.
  • Precise intake "breakpoints." One survey study put a turning point for total iron at about 18.4 mg/day,[55] another saw harm only from supplements above 18 mg/day,[56] and neither measured heme iron nor could show cause. What matters is whether the iron comes from supplements and what your stores are, not a decimal-point target.

Further reading

  • Mangan D. Iron: an underrated factor in aging. Aging (Albany NY) 2021.[57]
  • Daghlas I, Gill D. Genetically predicted iron status and life expectancy. Clinical Nutrition 2021.[58]
  • Timmers PRHJ et al. Multivariate genomic scan implicates novel loci and haem metabolism in human ageing. Nat Commun 2020.[59]
  • Tian Y et al. Iron metabolism in aging and age-related diseases. Int J Mol Sci 2022.[60]
  • Ward RJ et al. The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurology 2014.[61]
  • Lucas MR et al. HFE genotypes, haemochromatosis diagnosis and clinical outcomes at age 80 years: a prospective cohort study in the UK Biobank. BMJ Open 2024.[62]
  • Zacharski LR et al. Reduction of iron stores and cardiovascular outcomes in peripheral arterial disease (FeAST). JAMA 2007.[63]
  • Devos D et al. Trial of deferiprone in Parkinson's disease (FAIRPARK-II). New England Journal of Medicine 2022.[64]
  • Ayton S et al. Deferiprone in Alzheimer disease: a randomized clinical trial. JAMA Neurology 2025.[65]
  • Wang F et al. Integration of epidemiological and blood biomarker analysis links haem iron intake to increased type 2 diabetes risk. Nat Metab 2024.[66]
  • Guralnik JM et al. Prevalence of anemia in persons 65 years and older in the United States. Blood 2004.[67]
  • Moreno MA et al. Blood-based biomarkers in centenarians and non-centenarians: a matched, population-based retrospective cohort study. Biogerontology 2025.[68]

— § —